Nvidia-Arm plays "strong-Intel" card in UK deal probe
By Peter Clarke, eeNews Europe (January 11, 2022)
Arm has failed to break into the data center and PC markets significantly because of the strength of Intel and its x86 architecture and therefore Arm needs to be bought by Nvidia to prosper, according to a 28-page submission to UK government's Competition and Markets Authority.
The paper – from GPU chip vendor Nvidia and IP licensor Arm – provides multiple arguments in favour of allowing the former to acquire the latter IP and has been published by the CMA an initial submission as part of the 'Phase 2' investigation of the deal (see UK orders more scrutiny of Nvidia-ARM deal).
The deal was originally proposed back in September 2020 but it has received a lot of criticism on the basis that Nvidia competes with companies that are licensees of ARM cores and architecture. The deal is facing scrutiny by competition authorities in the UK, Europe, the US and China.
There is the possibility that one or other of these may block the deal altogether Extended inquiries mean that the deal is likely to miss a target date of March 2021, which would be 18 months from the deal's announcement.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Arm Ltd Hot IP
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design